Butterfly Network, Inc. Stock Price

In a nut shell, I saw Butterfly Network as a medical break through and bought a few hundred shares at a $1.55/shr. and the following news confirmed my reasoning of buying; On November 17, 2025, Butterfly Network’s subsidiary signed a five-year co-development and licensing agreement with Midjourney for exclusive access to its semiconductor-based ultrasound technology, securing a US$15 million upfront payment, US$10 million annual license fees, and further milestone and revenue-sharing potential.Read more

Key Takeaways Delays in closing key enterprise deals, provider hesitancy, and global funding uncertainty may hinder Butterfly Network's revenue growth and widespread adoption. High R&D spending and market commoditization risks could limit margin expansion and delay sustainable profitability despite growing commercial interest and an expanding platform ecosystem.Read more

Key Takeaways Expanding enterprise deals, clinical AI apps, and HomeCare pilots position Butterfly for growth in recurring digital revenue aligned with decentralized, accessible healthcare trends. Product and software innovations, cost reductions, and successful commercialization efforts support higher adoption, improved gross margins, and pave the way to scalable profitability.Read more

Key Takeaways Butterfly's advancements in AI-driven imaging and ecosystem development position it for accelerating mass adoption, top-line growth, and margin expansion within enterprise healthcare. Early-mover advantages in global deployment and home care applications could drive new, recurring, and higher-quality revenue streams as healthcare shifts to more decentralized models.Read more